Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Multicenter Retrospective-prospective Study of Patients With Active Moderate to Severe SLE

NCT06759519 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06759519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Multicenter Retrospective-prospective Study of Patients With Active Moderate to Severe SLE
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 30, 2024
Completion date
September 19, 2025
Enrollment
637 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus